Glutathione

Glutathione Research Overview

Glutathione is a tripeptide of glutamate, cysteine and glycine that every cell makes as its main antioxidant. It is studied by injection, IV, oral, liposomal or nebulized routes for oxidative stress, liver support, immune health and skin lightening.

Also known as: GSH, L-Glutathione reduced, Gamma-glutamylcysteinylglycine, Tationil

Background

Glutathione is technically a peptide, though an unusual one: the glutamate is joined through its side chain rather than the normal backbone bond, which protects it from most peptidases. It is present at high concentration in virtually every cell, where it neutralizes reactive oxygen species, recycles vitamins C and E, and helps the liver bind and excrete toxins and drug metabolites. Levels fall with age, illness, poor diet and heavy alcohol use, and low glutathione is associated with a long list of chronic conditions.

The problem with taking glutathione is getting it into cells. Standard oral glutathione is largely broken down in the gut, although a few controlled studies have shown modest increases in blood and tissue levels with sustained daily administration parameters. Liposomal and sublingual forms improve absorption. Intravenous glutathione delivers high plasma levels but the peptide is cleared quickly and cells still have to take up the components. N-acetylcysteine, which supplies the limiting amino acid cysteine, is a well studied way to raise glutathione from the inside.

Human evidence exists for several uses. IV glutathione is used as an approved adjunct to cisplatin chemotherapy in some countries to reduce nerve toxicity. Trials for Parkinson's disease, cystic fibrosis (nebulized) and fatty liver have shown small or inconsistent benefits. Skin lightening via IV glutathione is popular in parts of Asia but poorly supported and carries real risks from unregulated infusions. Injectable use for general wellness is common in the peptide community, usually 200 to 600 mg several times a week.

Mechanistic Profile

Glutathione works as a reducing agent. The thiol group on its cysteine donates electrons to neutralize free radicals and peroxides, and the enzyme glutathione peroxidase uses it to break down hydrogen peroxide and lipid peroxides. Once oxidized, two glutathione molecules join as GSSG and are recycled back by glutathione reductase using NADPH. In the liver, glutathione S-transferases attach it to toxins and drug metabolites so they can be excreted. It also keeps protein thiols in their correct state, supports mitochondrial function, and regulates the redox-sensitive signaling that controls inflammation and cell survival. Its effect on skin pigmentation comes from inhibiting tyrosinase and shifting melanin production toward the lighter pheomelanin form.

Reported Research Findings

• (human RCT)

• IV glutathione reduced cisplatin-induced neurotoxicity in cancer subjects without reducing chemotherapy efficacy. (human RCT)

• Oral glutathione produced measurable skin lightening in small trials in Asian populations over 4 to 12 weeks. (human pilot)

• Intranasal or IV glutathione in Parkinson's disease showed only marginal or no clinical benefit in controlled trials. (human RCT)

• Nebulized glutathione improved lung function measures in some cystic fibrosis trials but not others. (human RCT)

Analytical Validation, Formulation and Storage

• Purity: 99% or higher as verified by HPLC, with a third-party certificate of analysis available per batch.

• Formulation: lyophilised (freeze-dried) powder in a sterile sealed glass vial, to be reconstituted with an appropriate solvent for laboratory use.

• Reported half-life: Approximately 10-15 minutes in plasma; intracellular turnover measured in hours to days.

• Storage: keep lyophilised material cool, dark and dry (long-term at or below -20 °C). Store reconstituted solutions refrigerated, avoid repeated freeze-thaw cycles and use within laboratory-defined windows.

Selected Literature

• Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition, 2015.

• Glutathione in the prevention of cisplatin-induced neurotoxicity (review of clinical trials). Annals of Oncology, 1997.

• Glutathione as a skin whitening agent: facts, myths, evidence and controversies (review). Indian Journal of Dermatology, Venereology and Leprology, 2016.

• Glutathione: overview of its protective roles, measurement, and biosynthesis (review). Molecular Aspects of Medicine, 2009.

Cloud Aminos supplies Glutathione as a high-purity research material intended strictly for controlled laboratory use in vitro or in established animal models. This compound is not approved as a drug, diagnostic or dietary ingredient and is not manufactured, packaged or marketed for human consumption, self-experimentation, clinical application or any use outside properly designed and ethically approved research protocols.